Is uACR the key to cardiovascular and kidney disease prevention?
UC nephrologist explains how physicians can use the testing
As a precision biomarker, the urinary albumin-to-creatinine ratio (uACR) can guide physicians toward personalized, patient-centered prevention and treatment of both cardiovascular disease (CVD) and chronic kidney disease (CKD), according to new data published in the Journal of Internal Medicine.
As MedCentral recently reported, an elevated urine albumin-to-creatinine ratio indicates that the kidneys are stressed, which may be due to increased intraglomerular pressure resulting from hypertension, poorly controlled glucose levels, obesity or a combination of all three.
Prakash Gudsoorkar, MD, associate professor of clinical medicine in the Division of Nephrology in the Department of Internal Medicine at the University of Cincinnati College of Medicine and UC Health nephrologist, said interpretation of uACR for personalized risk assessment requires confirmation of persistent elevation over three months and avoidance of testing during acute illness. This is in addition to “repeat confirmation of elevated random values (ideally using the first morning urine specimen) and integration with eGFR to define combined cardiovascular and CKD progression risk,” he said.
Read the full MedCentral article for treatment response to the biomarker.
Featured image at top: Photo/iStock.
Related Stories
Phenols, found in many products, could upset heart's rhythms
October 7, 2024
Chemicals called environmental phenols include food preservatives, plastics ingredients such as BPA and the parabens in shampoos, so they are ubiquitous in everyday life. Now, University of Cincinnati research suggests that higher exposure to phenols might trigger changes in the heart's electrical system and rhythms.
Researchers work to make blood cancer a manageable disease
September 17, 2025
During Blood Cancer Awareness Month, Spectrum News and MSN highlighted researchers in the University of Cincinnati Cancer Center’s Leukemia and Drug Development Lab working to make blood cancer a manageable illness and bring new treatments to patients more efficiently than ever before.
Nephrologists miss opportunities to discuss contraceptive use with women with chronic kidney disease
November 7, 2025
Discussions about contraceptive use for women with chronic kidney disease are often avoided by nephrologists, according to University of Cincinnati data presented this week at the American Society of Nephrology's Kidney Week global. meeting in Houston. Nephrologists reported that they see the importance of reproductive health but feel ill-equipped to discuss it with patients. Discomfort, limited training and confusing guidance were among the key barriers to discussions.